Swedish Institute / Skåne University Hospital / / /
IndustryTerm
cancer prevention / tobacco products / designed reimbursement systems / treatment of lung cancer / medical technology / prevention of lung cancer / cancer care / oncology services / health care systems / health systems / treatment for cancer / /
MedicalCondition
colorectal and prostate cancer / both colorectal cancer / Colorectal cancer / older / new cancer / Executive Summary Cancer / Action Against Cancer / Age-standardized overall cancer / non-melanoma skin cancer / hepatitis B / obesity / neck and oropharyngeal cancer / innovative cancer / Prostate cancer / cardiovascular diseases / breast cancer / comprehensive cancer / malignant neoplasms / breast and colorectal cancer / cancers / nonmelanoma skin cancer / common cancer / cancer / disease / overall cancer / HPV / cervical cancer / European Code Against Cancer / real cancer / newly diagnosed cancer / commonly diagnosed cancer / Lung cancer / virus infection / high quality cancer / selected cancer / liver cancer / diseases / HPV-related cancers / Europe Against Cancer / lung and prostate cancer / elderly cancer / nationwide cancer / control cancer / /
MedicalTreatment
vaccination / vaccinations / /
Organization
Stockholm School of Economics / Stockholm / Swedish Institute for Health Economics / Stockholm School of Economics / European Parliament / Skåne University Hospital / Council of the European Union / European Centre for Disease Prevention and Control / European Commission / European Union / /
Person
Nils Wilking Karolinska Institutet / Nils Wilking / Thomas Hofmarcher / / /
ACCESS TO HIGH-QUALITY ONCOLOGY CARE ACROSS EUROPE Thomas Hofmarcher, IHE Bengt Jönsson, Stockholm School of Economics Nils Wilking, Karolinska Institutet and Skåne University Hospital